Connecticut Children's, 399 Farmington Ave, Farmington, CT 06032, United States; Univesity of Hartford, 200 Bloomfield Ave, West Harford, CT 06117, United States.
Connecticut Children's, 399 Farmington Ave, Farmington, CT 06032, United States.
Gait Posture. 2020 Mar;77:236-242. doi: 10.1016/j.gaitpost.2020.01.027. Epub 2020 Feb 1.
Charcot-Marie-Tooth (CMT) disease is an inherited peripheral neuropathy that causes progressive distal extremity nerve degeneration and muscle atrophy which can negatively impact function, gait and quality of life. The purpose of this study was to determine if differences exist in gait patterns, clinical examination and functional measures between CMT type I (CMT1) and type II (CMT2) in childhood to young adults. It was hypothesized that individuals with CMT2 would present with greater ankle weakness, increased and/or prolonged ankle dorsiflexion in stance during gait and demonstrate greater disease severity on the CMT Pediatric Scale (CMTPedS) compared to CMT1.
Twenty-seven individuals diagnosed with CMT1 or CMT2 underwent three-dimensional gait analysis, clinical examination and evaluation of disease severity using the CMTPedS. Subjects groups were divided based on CMT type: CMT1 (n = 20) and CMT2 (n = 7).
CMT2 group presented with a trend towards increased plantar flexion weakness compared to CMT1 of 61.1 ± 58.1 N to 137.9 ± 51.4 N (p < 0.012), respectively. CMT2 presented with significantly decreased dorsiflexion strength, 31.9 ± 30.9 N, compared to CMT1, 80.4 ± 37.4 N, (p < 0.0052) which negatively influenced gait patterns in CMT2. Associated gait findings demonstrated CMT2 group with significantly decreased peak ankle power generation in stance compared to CMT1 (1.46 ± 0.39 W/kg to 3.13 ± 0.98 W/kg respectively) (p < 0.0001). CMT1 was more likely to demonstrate a dorsiflexion moment in loading response than CMT2. There was a consistent trend of a higher score and therefore greater disease severity for CMT2 based on CMTPedS.
Study results suggest that at a given age, individuals with CMT2 have greater limitations in terms of gait function and disease severity than individuals with CMT1. Overall the CMT2 was shown to have greater gait limitations at the ankle during stance and swing with associated compensatory mechanisms at the knee and hip in swing.
Charcot-Marie-Tooth(CMT)病是一种遗传性周围神经病,导致远端肢体神经进行性退行性变和肌肉萎缩,从而对功能、步态和生活质量产生负面影响。本研究的目的是确定在儿童和青年时期,CMT 1 型(CMT1)和 2 型(CMT2)之间的步态模式、临床检查和功能测量是否存在差异。研究假设 CMT2 个体在步态中会出现更大的踝关节无力,在站立时出现更大的和/或延长的踝关节背屈,并且在 CMT 儿科量表(CMTPedS)上表现出更大的疾病严重程度,与 CMT1 相比。
27 名被诊断为 CMT1 或 CMT2 的个体接受了三维步态分析、临床检查和使用 CMTPedS 评估疾病严重程度。根据 CMT 类型将受试者分为两组:CMT1(n=20)和 CMT2(n=7)。
CMT2 组与 CMT1 相比,出现了向心趋势,表现为跖屈无力增加,分别为 61.1±58.1 N 至 137.9±51.4 N(p<0.012)。CMT2 呈现出明显的背屈力下降,为 31.9±30.9 N,而 CMT1 为 80.4±37.4 N(p<0.0052),这对 CMT2 的步态模式产生了负面影响。相关的步态发现表明,CMT2 组在站立时的峰值踝关节功率生成明显低于 CMT1 组(分别为 1.46±0.39 W/kg 和 3.13±0.98 W/kg)(p<0.0001)。CMT1 比 CMT2 更有可能在负荷反应中表现出背屈力矩。CMTPedS 显示 CMT2 的得分更高,疾病严重程度更大,这是一个一致的趋势。
研究结果表明,在给定的年龄,CMT2 个体在步态功能和疾病严重程度方面比 CMT1 个体有更大的限制。总体而言,CMT2 在站立和摆动期间在踝关节处表现出更大的步态限制,并在摆动期间在膝关节和髋关节处表现出相关的代偿机制。